| Year |
Citation |
Score |
| 2023 |
Tao S, Yang EJ, Zong G, Mou PK, Ren G, Pu Y, Chen L, Kwon HJ, Zhou J, Hu Z, Khosravi A, Zhang Q, Du Y, Shi WQ, Shim JS. ER translocon inhibitor ipomoeassin F inhibits triple-negative breast cancer growth via blocking ER molecular chaperones. International Journal of Biological Sciences. 19: 4020-4035. PMID 37705743 DOI: 10.7150/ijbs.82012 |
0.371 |
|
| 2023 |
Ren G, Yang EJ, Tao S, Mou PK, Pu Y, Chen LJ, Shim JS. MDM2 inhibition is synthetic lethal with PTEN loss in colorectal cancer cells via the p53-dependent mechanism. International Journal of Biological Sciences. 19: 3544-3557. PMID 37496993 DOI: 10.7150/ijbs.82566 |
0.32 |
|
| 2023 |
Wang X, Huang J, Liu F, Yu Q, Wang R, Wang J, Zhu Z, Yu J, Hou J, Shim JS, Jiang W, Li Z, Zhang Y, Dang Y. Aurora A kinase inhibition elevates PD-L1 expression and compromises its anti-tumor efficacy. The Journal of Clinical Investigation. PMID 36928177 DOI: 10.1172/JCI161929 |
0.589 |
|
| 2022 |
Shi C, Tao S, Ren G, Yang EJ, Shu X, Mou PK, Liu Y, Dang Y, Xu X, Shim JS. Aurora kinase A inhibition induces synthetic lethality in SMAD4-deficient colorectal cancer cells via spindle assembly checkpoint activation. Oncogene. PMID 35393542 DOI: 10.1038/s41388-022-02293-y |
0.676 |
|
| 2021 |
Zhang L, Chen C, Fu J, Lilley B, Berlinicke C, Hansen B, Ding D, Wang G, Wang T, Shou D, Ye Y, Mulligan T, Emmerich K, Saxena MT, Hall KR, ... ... Shim JS, et al. Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa. Elife. 10. PMID 34184634 DOI: 10.7554/eLife.57245 |
0.316 |
|
| 2020 |
Shi C, Yang EJ, Liu Y, Mou PK, Ren G, Shim JS. Bromodomain and extra-terminal motif (BET) inhibition is synthetic lethal with loss of SMAD4 in colorectal cancer cells via restoring the loss of MYC repression. Oncogene. PMID 33293694 DOI: 10.1038/s41388-020-01580-w |
0.382 |
|
| 2020 |
Hwang HY, Shim JS, Kim D, Kwon HJ. Antidepressant drug sertraline modulates AMPK-MTOR signaling-mediated autophagy via targeting mitochondrial VDAC1 protein. Autophagy. PMID 33124469 DOI: 10.1080/15548627.2020.1841953 |
0.363 |
|
| 2020 |
Liu Y, Yang EJ, Shi C, Mou PK, Zhang B, Wu C, Lyu J, Shim JS. Histone Acetyltransferase (HAT) P300/CBP Inhibitors Induce Synthetic Lethality in PTEN-Deficient Colorectal Cancer Cells through Destabilizing AKT. International Journal of Biological Sciences. 16: 1774-1784. PMID 32398948 DOI: 10.7150/Ijbs.42197 |
0.414 |
|
| 2020 |
Zhang B, Lyu J, Yang EJ, Liu Y, Wu C, Pardeshi L, Tan K, Chen Q, Xu X, Deng CX, Shim JS. Class I histone deacetylase inhibition is synthetic lethal with BRCA1 deficiency in breast cancer cells. Acta Pharmaceutica Sinica. B. 10: 615-627. PMID 32322466 DOI: 10.1016/J.Apsb.2019.08.008 |
0.347 |
|
| 2019 |
Lyu J, Yang EJ, Shim JS. Cholesterol Trafficking: An Emerging Therapeutic Target for Angiogenesis and Cancer. Cells. 8. PMID 31035320 DOI: 10.3390/Cells8050389 |
0.461 |
|
| 2018 |
Lyu J, Yang EJ, Head SA, Ai N, Zhang B, Wu C, Li RJ, Liu Y, Chakravarty H, Zhang S, Tam KY, Dang Y, Kwon HJ, Ge W, Liu JO, ... Shim JS, et al. Astemizole Inhibits mTOR Signaling and Angiogenesis by Blocking Cholesterol Trafficking. International Journal of Biological Sciences. 14: 1175-1185. PMID 30123067 DOI: 10.7150/Ijbs.26011 |
0.793 |
|
| 2018 |
Liu Y, Yang EJ, Zhang B, Miao Z, Wu C, Lyu J, Tan K, Wai Poon TC, Shim JS. PTEN deficiency confers colorectal cancer cell resistance to dual inhibitors of FLT3 and aurora kinase A. Cancer Letters. PMID 30118842 DOI: 10.1016/J.Canlet.2018.08.011 |
0.451 |
|
| 2018 |
Wu C, Lyu J, Yang EJ, Liu Y, Zhang B, Shim JS. Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells. Nature Communications. 9: 3212. PMID 30097580 DOI: 10.1038/S41467-018-05694-4 |
0.432 |
|
| 2018 |
Zhang B, Lyu J, Liu Y, Wu C, Yang EJ, Pardeshi L, Tan K, Wong KH, Chen Q, Xu X, Deng CX, Shim JS. BRCA1 deficiency sensitizes breast cancer cells to bromodomain and extra-terminal domain (BET) inhibition. Oncogene. PMID 30042414 DOI: 10.1038/S41388-018-0408-8 |
0.345 |
|
| 2017 |
Lyu J, Yang EJ, Head SA, Ai N, Zhang B, Wu C, Li RJ, Liu Y, Yang C, Dang Y, Kwon HJ, Ge W, Liu JO, Shim JS. Pharmacological blockade of cholesterol trafficking by cepharanthine in endothelial cells suppresses angiogenesis and tumor growth. Cancer Letters. PMID 28923401 DOI: 10.1016/J.Canlet.2017.09.009 |
0.813 |
|
| 2017 |
Head SA, Shi WQ, Yang EJ, Nacev BA, Hong SY, Pasunooti KK, Li RJ, Shim JS, Liu JO. Simultaneous Targeting of NPC1 and VDAC1 by Itraconazole Leads to Synergistic Inhibition of mTOR Signaling and Angiogenesis. Acs Chemical Biology. 12: 174-182. PMID 28103683 DOI: 10.1021/Acschembio.6B00849 |
0.753 |
|
| 2016 |
Cho YS, Yen CN, Shim JS, Kang DH, Kang SW, Liu JO, Kwon HJ. Antidepressant indatraline induces autophagy and inhibits restenosis via suppression of mTOR/S6 kinase signaling pathway. Scientific Reports. 6: 34655. PMID 27694974 DOI: 10.1038/Srep34655 |
0.481 |
|
| 2016 |
Du B, Shim JS. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer. Molecules (Basel, Switzerland). 21. PMID 27455225 DOI: 10.3390/Molecules21070965 |
0.402 |
|
| 2016 |
Yang EJ, Wu C, Liu Y, Lv J, Shim JS. Revisiting Non-Cancer Drugs for Cancer Therapy. Current Topics in Medicinal Chemistry. PMID 26881712 DOI: 10.2174/1568026616666160216154441 |
0.38 |
|
| 2016 |
Shim JS, Li RJ, Bumpus N, Head S, Pasunooti K, Yang EJ, Lv J, Shi W, Liu JO. Divergence of Anti-angiogenic Activity and Hepatotoxicity of Different Stereoisomers of Itraconazole. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26801248 DOI: 10.1158/1078-0432.Ccr-15-1888 |
0.779 |
|
| 2015 |
Head SA, Shi W, Zhao L, Gorshkov K, Pasunooti K, Chen Y, Deng Z, Li RJ, Shim JS, Tan W, Hartung T, Zhang J, Zhao Y, Colombini M, Liu JO. Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 26655341 DOI: 10.1073/Pnas.1512867112 |
0.792 |
|
| 2015 |
Kim NH, Pham NB, Quinn RJ, Shim JS, Cho H, Cho SM, Park SW, Kim JH, Seok SH, Oh JW, Kwon HJ. The Small Molecule R-(-)-β-O-Methylsynephrine Binds to Nucleoporin 153 kDa and Inhibits Angiogenesis. International Journal of Biological Sciences. 11: 1088-99. PMID 26221075 DOI: 10.7150/Ijbs.10603 |
0.43 |
|
| 2015 |
Wang G, Rajpurohit SK, Delaspre F, Walker SL, White DT, Ceasrine A, Kuruvilla R, Li RJ, Shim JS, Liu JO, Parsons MJ, Mumm JS. First quantitative high-throughput screen in zebrafish identifies novel pathways for increasing pancreatic β-cell mass. Elife. 4. PMID 26218223 DOI: 10.7554/Elife.08261 |
0.713 |
|
| 2015 |
He R, Yu ZH, Zhang RY, Wu L, Gunawan AM, Lane BS, Shim JS, Zeng LF, He Y, Chen L, Wells CD, Liu JO, Zhang ZY. Exploring the Existing Drug Space for Novel pTyr Mimetic and SHP2 Inhibitors. Acs Medicinal Chemistry Letters. 6: 782-6. PMID 26191366 DOI: 10.1021/Acsmedchemlett.5B00118 |
0.549 |
|
| 2015 |
Lv J, Shim JS. Existing drugs and their application in drug discovery targeting cancer stem cells. Archives of Pharmacal Research. 38: 1617-26. PMID 26152874 DOI: 10.1007/S12272-015-0628-1 |
0.426 |
|
| 2015 |
Shim JS, Li RJ, Lv J, Head SA, Yang EJ, Liu JO. Inhibition of angiogenesis by selective estrogen receptor modulators through blockade of cholesterol trafficking rather than estrogen receptor antagonism. Cancer Letters. 362: 106-15. PMID 25799952 DOI: 10.1016/J.Canlet.2015.03.022 |
0.805 |
|
| 2015 |
Wang G, Rajpurohit SK, Delaspre F, Walker SL, White DT, Ceasrine A, Kuruvilla R, Li R, Shim JS, Liu JO, Parsons MJ, Mumm JS. Author response: First quantitative high-throughput screen in zebrafish identifies novel pathways for increasing pancreatic β-cell mass Elife. DOI: 10.7554/Elife.08261.023 |
0.679 |
|
| 2014 |
Shim JS, Liu JO. Recent advances in drug repositioning for the discovery of new anticancer drugs. International Journal of Biological Sciences. 10: 654-63. PMID 25013375 DOI: 10.7150/Ijbs.9224 |
0.434 |
|
| 2014 |
Park H, Shim JS, Kim BS, Jung HJ, Huh TL, Kwon HJ. Purpurin inhibits adipocyte-derived leucine aminopeptidase and angiogenesis in a zebrafish model. Biochemical and Biophysical Research Communications. 450: 561-7. PMID 24928393 DOI: 10.1016/J.Bbrc.2014.06.017 |
0.5 |
|
| 2014 |
Wang M, Shim JS, Li RJ, Dang Y, He Q, Das M, Liu JO. Identification of an old antibiotic clofoctol as a novel activator of unfolded protein response pathways and an inhibitor of prostate cancer. British Journal of Pharmacology. 171: 4478-89. PMID 24903412 DOI: 10.1111/Bph.12800 |
0.756 |
|
| 2014 |
Wissing MD, Dadon T, Kim E, Piontek KB, Shim JS, Kaelber NS, Liu JO, Kachhap SK, Nelkin BD. Small-molecule screening of PC3 prostate cancer cells identifies tilorone dihydrochloride to selectively inhibit cell growth based on cyclin-dependent kinase 5 expression. Oncology Reports. 32: 419-24. PMID 24841903 DOI: 10.3892/Or.2014.3174 |
0.475 |
|
| 2014 |
Chalugun P, Shim JS, Korangath PC, Sukumar S, Liu JO. Abstract 443: Synergistic inhibition of HER2 positive breast cancer by triptolide and lapatinib Cancer Research. 74: 443-443. DOI: 10.1158/1538-7445.Am2014-443 |
0.445 |
|
| 2013 |
Zhang F, Bhat S, Gabelli SB, Chen X, Miller MS, Nacev BA, Cheng YL, Meyers DJ, Tenney K, Shim JS, Crews P, Amzel LM, Ma D, Liu JO. Pyridinylquinazolines selectively inhibit human methionine aminopeptidase-1 in cells Journal of Medicinal Chemistry. 56: 3996-4016. PMID 23634668 DOI: 10.1021/Jm400227Z |
0.776 |
|
| 2013 |
Bhat S, Shim JS, Liu JO. Tricyclic thiazoles are a new class of angiogenesis inhibitors. Bioorganic & Medicinal Chemistry Letters. 23: 2733-7. PMID 23518276 DOI: 10.1016/J.Bmcl.2013.02.067 |
0.738 |
|
| 2013 |
Wissing MD, Mendonca J, Kim E, Kim E, Shim JS, Kaelber NS, Kant H, Hammers H, Commes T, Van Diest PJ, Liu JO, Kachhap SK. Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells. Cancer Biology & Therapy. 14: 401-10. PMID 23377825 DOI: 10.4161/Cbt.23759 |
0.434 |
|
| 2013 |
Kamiyama H, Rauenzahn S, Shim JS, Karikari CA, Feldmann G, Hua L, Kamiyama M, Schuler FW, Lin MT, Beaty RM, Karanam B, Liang H, Mullendore ME, Mo G, Hidalgo M, et al. Personalized chemotherapy profiling using cancer cell lines from selectable mice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 1139-46. PMID 23340293 DOI: 10.1158/1078-0432.Ccr-12-2127 |
0.364 |
|
| 2013 |
Choi SM, Kim Y, Shim JS, Park JT, Wang RH, Leach SD, Liu JO, Deng C, Ye Z, Jang YY. Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells. Hepatology (Baltimore, Md.). 57: 2458-68. PMID 23325555 DOI: 10.1002/Hep.26237 |
0.445 |
|
| 2013 |
Kamiyama H, Rauenzahn S, Shim JS, Liu JO, Maitra A, Eshleman JR. Abstract 4155: Personalized chemosensitivity profiling of cancers isolated from genetically-engineered mice. Cancer Research. 73: 4155-4155. DOI: 10.1158/1538-7445.Am2013-4155 |
0.427 |
|
| 2013 |
Chalugun P, Shim J, Liu J. Abstract P2-09-18: Identification of synergistic drug combination for HER2 positive breast cancer Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P2-09-18 |
0.374 |
|
| 2012 |
Shim JS, Rao R, Beebe K, Neckers L, Han I, Nahta R, Liu JO. Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir. Journal of the National Cancer Institute. 104: 1576-90. PMID 23042933 DOI: 10.1093/Jnci/Djs396 |
0.449 |
|
| 2012 |
Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA, Liu JO, Pan D. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes & Development. 26: 1300-5. PMID 22677547 DOI: 10.1101/Gad.192856.112 |
0.454 |
|
| 2012 |
Bhat S, Shim JS, Zhang F, Chong CR, Liu JO. Substituted oxines inhibit endothelial cell proliferation and angiogenesis. Organic & Biomolecular Chemistry. 10: 2979-92. PMID 22391578 DOI: 10.1039/C2Ob06978D |
0.806 |
|
| 2011 |
Platz EA, Yegnasubramanian S, Liu JO, Chong CR, Shim JS, Kenfield SA, Stampfer MJ, Willett WC, Giovannucci E, Nelson WG. A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment. Cancer Discovery. 1: 68-77. PMID 22140654 DOI: 10.1158/2159-8274.Cd-10-0020 |
0.711 |
|
| 2011 |
Rovira M, Huang W, Yusuff S, Shim JS, Ferrante AA, Liu JO, Parsons MJ. Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiation. Proceedings of the National Academy of Sciences of the United States of America. 108: 19264-9. PMID 22084084 DOI: 10.1073/Pnas.1113081108 |
0.415 |
|
| 2011 |
Lin J, Haffner MC, Zhang Y, Lee BH, Brennen WN, Britton J, Kachhap SK, Shim JS, Liu JO, Nelson WG, Yegnasubramanian S, Carducci MA. Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth. The Prostate. 71: 333-43. PMID 20809552 DOI: 10.1002/Pros.21247 |
0.433 |
|
| 2011 |
Wissing MD, Kim E, Dadon T, Shim JS, Mendonca J, Piontek K, Liu JO, Carducci MA, Kachhap SK, Nelkin BD. Abstract 2976: Small molecule screening of prostate and pancreatic cancer cell lines identifies tilorone dihydrochloride as a compound that selectively inhibits growth in cells with inhibited cyclin-dependent kinase 5 Cancer Research. 71: 2976-2976. DOI: 10.1158/1538-7445.Am2011-2976 |
0.502 |
|
| 2010 |
Shim JS, Matsui Y, Bhat S, Nacev BA, Xu J, Bhang HE, Dhara S, Han KC, Chong CR, Pomper MG, So A, Liu JO. Effect of nitroxoline on angiogenesis and growth of human bladder cancer. Journal of the National Cancer Institute. 102: 1855-73. PMID 21088277 DOI: 10.1093/Jnci/Djq457 |
0.79 |
|
| 2010 |
Jung HJ, Kim JH, Shim JS, Kwon HJ. A novel Ca2+/calmodulin antagonist HBC inhibits angiogenesis and down-regulates hypoxia-inducible factor. The Journal of Biological Chemistry. 285: 25867-74. PMID 20554536 DOI: 10.1074/Jbc.M110.135632 |
0.438 |
|
| 2010 |
Jung HJ, Shim JS, Lee J, Song YM, Park KC, Choi SH, Kim ND, Yoon JH, Mungai PT, Schumacker PT, Kwon HJ. Terpestacin inhibits tumor angiogenesis by targeting UQCRB of mitochondrial complex III and suppressing hypoxia-induced reactive oxygen species production and cellular oxygen sensing. The Journal of Biological Chemistry. 285: 11584-95. PMID 20145250 DOI: 10.1074/Jbc.M109.087809 |
0.375 |
|
| 2009 |
Jung HJ, Shim JS, Park J, Ha HJ, Kim JH, Kim JG, Kim ND, Yoon JH, Kwon HJ. Identification and validation of calmodulin as a binding protein of an anti-proliferative small molecule 3,4-dihydroisoquinolinium salt. Proteomics. Clinical Applications. 3: 423-32. PMID 21136969 DOI: 10.1002/Prca.200800060 |
0.399 |
|
| 2009 |
Shim JS, Kim DH, Jung HJ, Kim JH, Lim D, Lee S, Kim K, Ahn JW, Yoo J, Rho J, Shin J, Kwon HJ. Erratum to “Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation” [Bioorg. Med. Chem. 10 (2002) (2987–2992)] Bioorganic & Medicinal Chemistry. 17: 7073. DOI: 10.1016/J.Bmc.2009.01.002 |
0.467 |
|
| 2008 |
Shim JS, Park HM, Lee J, Kwon HJ. Global and focused transcriptional profiling of small molecule aminopeptidase N inhibitor reveals its mechanism of angiogenesis inhibition. Biochemical and Biophysical Research Communications. 371: 99-103. PMID 18413233 DOI: 10.1016/J.Bbrc.2008.04.023 |
0.48 |
|
| 2007 |
Yang E, Shim JS, Woo HJ, Kim KW, Kwon HJ. Aminopeptidase N/CD13 induces angiogenesis through interaction with a pro-angiogenic protein, galectin-3. Biochemical and Biophysical Research Communications. 363: 336-41. PMID 17888402 DOI: 10.1016/J.Bbrc.2007.08.179 |
0.416 |
|
| 2007 |
Jung HJ, Shim JS, Suh YG, Kim YM, Ono M, Kwon HJ. Potent inhibition of in vivo angiogenesis and tumor growth by a novel cyclooxygenase-2 inhibitor, enoic acanthoic acid. Cancer Science. 98: 1943-8. PMID 17888030 DOI: 10.1111/J.1349-7006.2007.00617.X |
0.517 |
|
| 2007 |
Shim JS, Lee J, Kim KN, Kwon HJ. Development of a new Ca2+/calmodulin antagonist and its anti-proliferative activity against colorectal cancer cells. Biochemical and Biophysical Research Communications. 359: 747-51. PMID 17559805 DOI: 10.1016/J.Bbrc.2007.05.174 |
0.38 |
|
| 2007 |
Choi HS, Shim JS, Kim JA, Kang SW, Kwon HJ. Discovery of gliotoxin as a new small molecule targeting thioredoxin redox system. Biochemical and Biophysical Research Communications. 359: 523-8. PMID 17544368 DOI: 10.1016/J.Bbrc.2007.05.139 |
0.35 |
|
| 2006 |
Jung HJ, Shim JS, Lee HB, Kim CJ, Kuwano T, Ono M, Kwon HJ. Embellistatin, a microtubule polymerization inhibitor, inhibits angiogenesis both in vitro and in vivo. Biochemical and Biophysical Research Communications. 353: 376-80. PMID 17184734 DOI: 10.1016/J.Bbrc.2006.12.026 |
0.523 |
|
| 2005 |
Shim JS, Lee HK, Park HM, Kim JO, Kim EK, Hwang KH, Kim KT, Park SW, Lee JH, Kwon HJ. Development of anangiogenesis-focused cDNA chip and validation of its functionality. Experimental & Molecular Medicine. 37: 365-70. PMID 16155413 DOI: 10.1038/Emm.2005.46 |
0.348 |
|
| 2005 |
Hur JM, Shim JS, Jung HJ, Kwon HJ. Cryptotanshinone but not tanshinone IIA inhibits angiogenesisin vitro. Experimental & Molecular Medicine. 37: 133-7. PMID 15886527 DOI: 10.1038/Emm.2005.18 |
0.467 |
|
| 2005 |
Lee J, Shim JS, Jung SA, Lee ST, Kwon HJ. N-hydroxy-2-(naphthalene-2-ylsulfanyl)-acetamide, a novel hydroxamic acid-based inhibitor of aminopeptidase N and its anti-angiogenic activity. Bioorganic & Medicinal Chemistry Letters. 15: 181-3. PMID 15582436 DOI: 10.1016/J.Bmcl.2004.10.010 |
0.426 |
|
| 2004 |
Shim JS, Kwon HJ. Chemical genetics for therapeutic target mining Expert Opinion On Therapeutic Targets. 8: 653-661. PMID 15584869 DOI: 10.1517/14728222.8.6.653 |
0.301 |
|
| 2004 |
Shim JS, Lee J, Park HJ, Park SJ, Kwon HJ. A new curcumin derivative, HBC, interferes with the cell cycle progression of colon cancer cells via antagonization of the Ca2+/calmodulin function. Chemistry & Biology. 11: 1455-63. PMID 15489172 DOI: 10.1016/J.Chembiol.2004.08.015 |
0.351 |
|
| 2004 |
Shim JS, Kim JH, Lee J, Kim SN, Kwon HJ. Anti-angiogenic activity of a homoisoflavanone from Cremastra appendiculata. Planta Medica. 70: 171-3. PMID 14994197 DOI: 10.1055/S-2004-815496 |
0.466 |
|
| 2004 |
Shim JS, Lee HS, Shin J, Kwon HJ. Psammaplin A, a marine natural product, inhibits aminopeptidase N and suppresses angiogenesis in vitro. Cancer Letters. 203: 163-9. PMID 14732224 DOI: 10.1016/J.Canlet.2003.08.036 |
0.51 |
|
| 2004 |
Shim JS, Kim DH, Kwon HJ. Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells. Oncogene. 23: 1704-11. PMID 14661058 DOI: 10.1038/Sj.Onc.1207289 |
0.338 |
|
| 2003 |
Shim JS, Kim JH, Cho HY, Yum YN, Kim SH, Park HJ, Shim BS, Choi SH, Kwon HJ. Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin. Chemistry & Biology. 10: 695-704. PMID 12954328 DOI: 10.1016/S1074-5521(03)00169-8 |
0.459 |
|
| 2003 |
Kim JH, Shim JS, Lee SK, Kim KW, Rha SY, Chung HC, Kwon HJ. Microarray-based analysis of anti-angiogenic activity of demethoxycurcumin on human umbilical vein endothelial cells: crucial involvement of the down-regulation of matrix metalloproteinase. Japanese Journal of Cancer Research : Gann. 93: 1378-85. PMID 12495478 DOI: 10.1111/J.1349-7006.2002.Tb01247.X |
0.379 |
|
| 2003 |
Shim JS, Kim DH, Jung HJ, Kim JH, Lim D, Lee SK, Kim KW, Ahn JW, Yoo JS, Rho JR, Shin J, Kwon HJ. Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation. Bioorganic & Medicinal Chemistry. 10: 2987-92. PMID 12110321 DOI: 10.1016/S0968-0896(02)00129-3 |
0.509 |
|
| 2003 |
Shim JS, Kim DH, Jung HJ, Kim JH, Lim D, Lee SK, Kim KW, Ahn JW, Yoo JS, Rho JR, Shin J, Kwon HJ. Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation. Bioorganic & Medicinal Chemistry. 10: 2439-44. PMID 12057633 DOI: 10.1016/s0968-0896(02)00116-5 |
0.414 |
|
| 2002 |
Kwon HJ, Shim JS, Kim JH, Cho HY, Yum YN, Kim SH, Yu J. Betulinic acid inhibits growth factor-induced in vitro angiogenesis via the modulation of mitochondrial function in endothelial cells. Japanese Journal of Cancer Research : Gann. 93: 417-25. PMID 11985792 DOI: 10.1111/J.1349-7006.2002.Tb01273.X |
0.401 |
|
| Show low-probability matches. |